Platinum-sensitive and platinum-resistant ovarian cancer tissues show differences in the relationships between mRNA levels of p53, ERCC1 and XPA

International Journal of Oncology

Volumn 8, Issue 2, 1996, Pages 313-317

  Yu, Jingjie ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

DNA repair; ERCC1; Ovarian cancer; p53; XPA

Indexed keywords

CARBOPLATIN; CISPLATIN; MESSENGER RNA; PLATINUM DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; OVARY CANCER; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0030070823     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.2.313     Document Type: Article

References (11)

1. Hoskins WJ and Rubin SC: Surgery in the treatment of patients with advanced ovarian cancer. Semin Oncol 18: 213-221, 1991.
2. Ozols RF and Young RC: Chemotherapy of ovarian cancer. Semin Oncol 18: 222-232, 1991.
3. Caldas C and McGuire WP: Taxol in epithelial ovarian cancer. Monogr Natl Cancer Inst 15: 155-159, 1993.
4. Parker RJ, Eastman A, Bostick-Bruton F and Reed E: Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J Clin Invest 87: 772-777, 1991.
5. Dabholkar M, Bostick-Bruton F, Weber C, Bohr VA, Egwuagu C and Reed E: ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. J Natl Cancer Inst 84: 1512-1517, 1992.
6. Masuda H, Tanaka T, Matsuda H and Kusaba I: Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum (II). Cancer Res 50: 1863-1866, 1990.
7. Cleaver JE: It was a very good year for DNA repair. Cell 76: 1-4, 1994.
8. Drapkin R, Sancar A and Reinberg D: Where transcription meets repair. Cell 77: 9-12, 1994.
9. Lee KB, Parker RJ, Bohr V, Cornelison T and Reed E: Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3. Carcinogenesis 14: 2177-2180, 1993.
10. Shivji MKK, Kenny MK and Wood RD: Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69: 367-374, 1992.
11. Dijt FJ, Fichtinger-Schepman AMJ, Berends F and Reedjik J: Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts. Cancer 48: 6058-6062, 1988.